[go: up one dir, main page]

KR20030039143A - Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material - Google Patents

Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material Download PDF

Info

Publication number
KR20030039143A
KR20030039143A KR1020010070086A KR20010070086A KR20030039143A KR 20030039143 A KR20030039143 A KR 20030039143A KR 1020010070086 A KR1020010070086 A KR 1020010070086A KR 20010070086 A KR20010070086 A KR 20010070086A KR 20030039143 A KR20030039143 A KR 20030039143A
Authority
KR
South Korea
Prior art keywords
compound
benzofuran compound
concentrating
extract
methanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020010070086A
Other languages
Korean (ko)
Inventor
유익동
윤봉식
강희철
Original Assignee
한국생명공학연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국생명공학연구원 filed Critical 한국생명공학연구원
Priority to KR1020010070086A priority Critical patent/KR20030039143A/en
Publication of KR20030039143A publication Critical patent/KR20030039143A/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Birds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: Benzofuran compounds derived from Suillus granulatus (L. ex Fr.) O. Kuntxe and an antioxidative composition containing the same compounds as an active ingredient are provided. The benzofuran compounds have antioxidative activity and no toxicity, so that they can be added to medicines, cosmetics and foods. CONSTITUTION: Benzofuran compounds represented by formula(1) are separated and purified by the steps of: dipping fruit bodies of Suillus granulatus (L. ex Fr.) O. Kuntxe in methanol for 3 days; concentrating the methanol extract under reduced pressure; extracting remnants with ethylacetate and concentrating the ethylacetate extract under reduced pressure; subjecting the methanol extract and the ethylacetate extract to silica gel column chromatography using CHCl3:MeOH to obtain an active fraction; concentrating the active fraction and subjecting it to Sephadex LH-20 column chromatography using CHCl3:MeOH(2:1).

Description

젖비단그물버섯 유래의 신규한 벤조퓨란계 화합물 및 이를 유효성분으로 하는 항산화 조성물 {Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material}Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material

본 발명은 젖비단그물버섯 유래의 신규한 벤조퓨란계 화합물 및 이를 유효성분으로 함유하는 항산화 조성물에 관한 것이다. 더욱 상세하게는, 본 발명은 젖비단그물버섯으로부터 순수하게 추출분리하여 얻은 항산화활성을 가지는 신규한 벤조퓨란계 화합물 및 이를 유효성분으로 함유하는 항산화 조성물에 관한 것이다.The present invention relates to a novel benzofuran compound derived from lactose net mushroom and an antioxidant composition containing the same as an active ingredient. More specifically, the present invention relates to a novel benzofuran compound having an antioxidant activity obtained by purely extracting and separating lactose net mushrooms and an antioxidant composition containing the same as an active ingredient.

활성산소는 뇌혈관 장애로 인한 뇌졸중, 심근경색, 당뇨병성 혈관장애, 고지혈증, 급성염증, 류마티스 질환, 알콜성 간염, 동맥경화, 발암, 노화등을 비롯한 다양한 질환의 직접 혹은 간접적인 유발원인이 되고 있다. 활성산소 소거물질은 이들 질병을 경감 혹은 예방할 수 있는 것으로 보고되고 있으며 미생물 및 식물체로부터 다양한 활성산소 소거물질이 발견되었고 의약용 혹은 화장품 및 식품 첨가물로 사용되고 있다.Free radicals are a direct or indirect cause of various diseases, including stroke, myocardial infarction, diabetic vascular disorders, hyperlipidemia, acute inflammation, rheumatic diseases, alcoholic hepatitis, arteriosclerosis, carcinogenesis, and aging due to cerebrovascular disorders. have. Active oxygen scavengers have been reported to reduce or prevent these diseases, and various active oxygen scavengers have been found in microorganisms and plants and are used as pharmaceuticals or cosmetics and food additives.

각종 산화반응, 화학약품, 식품, 인체질환 및 방사선 등에 의해 슈퍼옥사이드(superoxide, ·O2), 하이드록실라디칼(hydroxyl radical, ·OH) 및 과산화수소 (H2O2) 등과 같은 반응성이 큰 강한 활성산소와 유리라디칼(free radical)등이 생체내에 생성되면 이들에 의해서 불포화 지방산이 다량 함유된 세포막의 인지질이 산화되어 세포막에 지질 과산화물이 생성되게 된다. 세포막에 지질 과산화물이 축적되게 되면 세포막의 유동성과 기능성이 저하됨으로 세포의 전체적인 기능이 억제되고 세포의 구조도 변화하는 등 조직상에 국소적인 장해가 생기면서 각종 질환이 유발되게 되는 것이다. 따라서 인체내에 반응성이 큰 활성산소와 유리라디칼이 과량으로 축적되게 되면 뇌졸증, 심근경색, 당뇨병성 혈관장애, 고지혈증, 급성염증, 류마티스 질환, 알콜성 간염 등의 간장질환 등 각종 인체 질환을 일으키게 된다. 따라서 강력하면서도 독성이 없는 활성산소 소거물질은 각종 질병의 치료제 개발이나 노화방지용 화장품 첨가제 및 식품첨가제 등으로 매우 유용하게 활용될 것이다. 지금까지 항산화 화합물로는 BHT(butylated hydroxy toluene) 및 BHA(butylated hydroxyanisol) 등과 같은 합성 항산화제가 사용되어 왔으나 이들 BHT나 BHA는 항산화 활성은 우수하나 암 또는 기형을 유발할 수 있는 가능성이 매우 높아 계속적으로 사용할 수 없는 단점이 있었다. 따라서 천연물로부터 새로운 활성산소소거물질을 창출하여 독성이나 부작용이 전혀 없는 항산화제를 개발하는 것이 요구되고 있다.Highly reactive activity such as superoxide (OH 2 ), hydroxyl radical (OH) and hydrogen peroxide (H 2 O 2 ) due to various oxidation reactions, chemicals, food, human diseases and radiation When oxygen and free radicals are generated in vivo, the phospholipids of the cell membrane containing a large amount of unsaturated fatty acids are oxidized, thereby producing lipid peroxides on the cell membrane. Accumulation of lipid peroxides in the cell membrane reduces the fluidity and functionality of the cell membrane, thereby inhibiting the overall function of the cell and changing the structure of the cell. Therefore, if excessive reactive oxygen and free radicals accumulate in the human body, various human diseases such as stroke, myocardial infarction, diabetic vascular disorders, hyperlipidemia, acute inflammation, rheumatic diseases, alcoholic hepatitis, and the like are caused. Therefore, the active oxygen scavenger that is powerful but not toxic will be very useful as a therapeutic agent for various diseases or as an anti-aging cosmetic additive and food additive. Until now, synthetic antioxidants such as butylated hydroxy toluene (BHT) and butylated hydroxyanisol (BHA) have been used as antioxidant compounds. However, these BHT and BHA have excellent antioxidant activity but are highly likely to cause cancer or malformation. There was a disadvantage. Therefore, it is required to develop an antioxidant that has no toxicity or side effects by creating a new active oxygen scavenger from natural products.

본 발명자들은 상기와 같은 점을 감안하여 각종 버섯 및 약용식물을 채집하여 조사하던 중 젖비단그물버섯을 메탄올 추출한후 크로마토그래피를 이용하여 순수 분리정제하여 신규한 벤조퓨란계 화합물을 얻고 이의 화학구조 및 물리화학적 특성을 규명한 뒤 디피피에이치 라디칼 소거활성을 조사하여 항산화능력을 평가하고 이를 각종 화장품 제형에 활용함으로써 본 발명을 완성하였다.In view of the above, the present inventors collected and investigated various mushrooms and medicinal plants, and obtained pure benzofuran-based compounds by methanol extraction of lactose net mushrooms, and then chromatographic extraction to obtain novel benzofuran compounds. After physicochemical characteristics were investigated, the present invention was completed by evaluating the antioxidant activity by investigating DPH radical scavenging activity and using it in various cosmetic formulations.

따라서, 본 발명의 목적은 젖비단그물버섯으로부터 순수하게 분리정제하여 얻은 항산화활성을 가지는 신규한 벤조퓨란계 화합물을 제공함에 있다. 본 발명의 다른 목적은 젖비단그물버섯으로부터 순수하게 분리정제하여 얻은 항산화활성을 가지는 신규한 벤조퓨란계 화합물을 유효성분으로 함유하는 항산화 조성물을 제공함에 있다.Accordingly, an object of the present invention is to provide a novel benzofuran compound having antioxidant activity obtained by purely purified from lactose net mushroom. Another object of the present invention is to provide an antioxidant composition containing a novel benzofuran compound having an antioxidant activity obtained by purely separating and purifying from lactose net mushroom.

본 발명의 상기 목적은 젖비단그물버섯을 메탄올 추출한후 크로마토그래피를 이용하여 순수 분리정제하여 신규한 벤조퓨란계 화합물을 얻고 이의 화학구조 및 물리화학적 특성을 규명한 뒤 디피피에이치 라디칼 소거활성을 조사하여 항산화능력을 평가하고 이를 각종 화장품 제형에 활용함으로써 달성하였다.The object of the present invention is to extract novel benzofuran compound by methanol extraction of lactose net mushrooms and then purified by chromatography to investigate the chemical structure and physicochemical properties of the python H radical scavenging activity This was achieved by evaluating antioxidant capacity and using it in various cosmetic formulations.

이하 본 발명의 구성을 설명한다.Hereinafter, the configuration of the present invention.

본 발명은 젖비단그물버섯을 마쇄한후 메탄올로 추출하고 크로마토그래피를 이용하여 신규한 벤조퓨란계 화합물을 순수하게 분리정제하는 단계; 상기 단계에서 얻은 화합물의 화학구조 및 물리화학적 특성을 조사하는 단계; 상기 단계의 화합물을 각종 화장품 제형에 활용하는 단계로 구성된다.The present invention comprises the steps of pulverizing lactose net mushrooms and extracting with methanol, and purified and purified the novel benzofuran compound purely using chromatography; Examining the chemical structure and physicochemical properties of the compound obtained in the step; Comprising the step of using the compound of the various cosmetic formulations.

본 발명에 따른 신규한 벤조퓨란계 화합물 슐러신은 하기 화학식을 갖는다.The novel benzofuran compound Schulsine according to the present invention has the following formula.

본 발명에 따른 신규한 벤조퓨란계 화합물의 물리화학적 특성은 다음과 같다.Physical and chemical properties of the novel benzofuran compound according to the present invention are as follows.

성상: 황색의 분말Appearance: Yellow Powder

분자량: 370Molecular Weight: 370

분자식: C19H14O8 Molecular Formula: C 19 H 14 O 8

선광도: [α]D+ 4 (c1.0, MeOH)Radiance: [α] D + 4 ( c 1.0, MeOH)

질량분선 스펙트럼 : HREIMSm/z370.0705 [M]+ Mass Segmentation Spectrum: HREIMS m / z 370.0705 [M] +

EIMSm/z370 [M]+ EIMS m / z 370 [M] +

자외선흡수스펙트럼 : UVλmax (MeOH)(logε)UV absorption spectrum: UV λ max (MeOH) (log ε )

223 (sh) (3.56), 261 (3.21), 311 (sh) (3.30),223 (sh) (3.56), 261 (3.21), 311 (sh) (3.30),

348 (3.42) nm348 (3.42) nm

적외선스펙트럼 : IR (KBr)νmaxInfrared spectrum: IR (KBr) ν max

3412, 2924, 2852, 1728 (sh), 1703, 16113412, 2924, 2852, 1728 (sh), 1703, 1611

1523, 1490, 1439, 1386, 1284, 1218 cm-1 1523, 1490, 1439, 1386, 1284, 1218 cm -1

수소핵자기공명스펙트럼 : ppm (600 MHz)Hydrogen Magnetic Resonance Spectrum: ppm (600 MHz)

1H NMR (CD3OD) : 7.64 (1H, d,J= 2.0 Hz, H-2), 7.42 (1H, dd,J= 8.8, 2.0 Hz, H-6), 6.81 (1H, dd,J= 2.4, 1.0 Hz, H-8), 6.79 (1H, d,J= 8.8 Hz, H-5), 6.68 (1H, d,J= 8.8 Hz, H-5), 6.64(1H, ddd,J= 8.8, 2.4, 1.0 Hz, H-6), 4.15 (1H, br s, H-8b), 3.72 (3H, s, OCH 3);1H NMR (acetone-d 6 ) d 9.17 (1H, s, OH), 8.34 (2H, s, OH), 8.02 (1H, s, OH), 7.67 (1H, d,J= 2.2 Hz, H-2), 7.52 (1H, dd,J= 8.4, 2.2 Hz, H-6), 6.90 (1H, d,J= 8.4 Hz, H-5), 6.84 (1H, m, H-8), 6.69 (1H, m, H-5), 6.69 (1H, m, H-6), 4.27 (1H, br s, H-8b), 3.71 (3H, s, OCH 3) 1 H NMR (CD 3 OD): 7.64 (1H, d, J = 2.0 Hz, H-2), 7.42 (1H, dd, J = 8.8, 2.0 Hz, H-6), 6.81 (1H, dd, J = 2.4, 1.0 Hz, H-8), 6.79 (1H, d, J = 8.8 Hz, H-5), 6.68 (1H, d, J = 8.8 Hz, H-5), 6.64 (1H, ddd, J = 8.8, 2.4, 1.0 Hz, H-6), 4.15 (1H, br s, H-8b), 3.72 (3H, s, OC H 3 ); 1 H NMR (acetone- d 6 ) d 9.17 (1H, s, O H ), 8.34 (2H, s, O H ), 8.02 (1H, s, O H ), 7.67 (1H, d, J = 2.2 Hz , H-2), 7.52 (1H, dd, J = 8.4, 2.2 Hz, H-6), 6.90 (1H, d, J = 8.4 Hz, H-5), 6.84 (1H, m, H-8) , 6.69 (1H, m, H-5), 6.69 (1H, m, H-6), 4.27 (1H, br s, H-8b), 3.71 (3H, s, OC H 3 )

탄소핵자기공명스펙트럼 : ppm (150 MHz)Carbon Magnetic Resonance Spectrum: ppm (150 MHz)

13C NMR (CD3OD) : 197.8 (C-1), 173.5 (COOCH3), 153.8 (C-4a), 153.4 (C-7), 151.0 (C-2), 148.3 (C-4), 146.2 (C-3), 137.2 (C-3), 125.3 (C-1), 123.9(C-8a), 122.8 (C-6), 117.4 (C-6), 117.1 (C-2), 116.2 (C-5), 112.2 (C-8), 111.7 (C-5), 91.9 (C-3a), 56.9 (C-8b), 53.7 (COOCH3) 13 C NMR (CD 3 OD) : 197.8 (C-1), 173.5 (C OOCH 3), 153.8 (C-4a), 153.4 (C-7), 151.0 (C-2), 148.3 (C-4) , 146.2 (C-3), 137.2 (C-3), 125.3 (C-1), 123.9 (C-8a), 122.8 (C-6), 117.4 (C-6), 117.1 (C-2), 116.2 (C-5), 112.2 (C-8), 111.7 (C-5), 91.9 (C-3a), 56.9 (C-8b), 53.7 (COO C H 3 )

상기와 같은 물리화학적 특성 및 핵자기공명 스펙트럼의 해석으로부터 본 발명에 따른 화합물 슐러신은 신규한 벤조퓨란계 화합물로 규명되었다.From the analysis of the above physicochemical properties and nuclear magnetic resonance spectra, the compound Schullin according to the present invention was identified as a novel benzofuran compound.

본 발명에 따른 벤조퓨란계 화합물은 그물버섯(Suillus) 속에 속하는 버섯자실체 및 균사체 배양액으로부터 유기용매(알코올, 에테르, 아세톤등)에 의하여 추출, 초산에틸과 물의 분배, 컬럼크로마토그래피 등, 버섯성분의 분리 추출에 이용되는 공지의 방법을 단독 또는 적합하게 조합하여 용이하게 얻을 수가 있다. 조추출물은 필요에 따라서 상법에 따라서 더욱 정제할 수 있다.The benzofuran compound according to the present invention is extracted from an organic solvent (alcohol, ether, acetone, etc.) from mushroom fruit bodies and mycelium cultures belonging to the genus Mushroom ( Suillus ), distribution of ethyl acetate and water, column chromatography, etc. Known methods used for separation extraction can be easily obtained alone or in combination as appropriate. The crude extract can be further purified according to a commercial method as needed.

본 발명에서 사용하는 크로마토그래피에는 실리카겔 컬럼 크로마토그래피 (silica gel culumn chromatography), 엘에이취-20 컬럼 크로마토그래피(LH-20 culumn chromatography), 박층크로마토그래피(TLC; thin layer chromatography) 및 고성능 액체 크로마토그래피(high performance liquid chromatography) 등이 이용될 수 있다.Chromatography used in the present invention includes silica gel column chromatography, silica-20 column chromatography, thin layer chromatography (TLC) and high performance liquid chromatography (TLC). high performance liquid chromatography) and the like.

본 발명에 따른 신규한 벤조퓨란계 화합물 슐러신은 디피피에이치 라디칼을 소거하는 작용을 가지고 있으며 다른 디피피에이치 라디컬 소거 물질보다도 세포독성이 낮아서 생체내 항산화제로 활용할 수 있다.The novel benzofuran compound Schulsine according to the present invention has a function of scavenging DPP radicals and is lower in cytotoxicity than other DPH radical scavenging substances and thus can be utilized as an antioxidant in vivo.

본 발명에 따른 신규한 벤조퓨란계 화합물 슐러신은 탁월한 디피피에이치 라디칼 소거활성을 나타낼뿐만 아니라 안정성도 높아 항산화제로 식품, 음료 및 화장품등의 첨가제로 이용할 수 있다. 또한 생체내 항산화활성을 이용하여 각종 의약품으로 사용할 수도 있다.The novel benzofuran compound Schulsine according to the present invention not only shows excellent DPH radical scavenging activity but also has high stability and can be used as an additive for food, beverage and cosmetics as an antioxidant. In addition, it can also be used in various medicines by using the antioxidant activity in vivo.

의약품에 적용할 경우에는 본 발명에 따른 화합물 슐러신을 유효성분으로하여 상용되는 무기 또는 유기의 담체를 가하여 고체, 반고체 또는 액상의 형태로 경구투여제 혹은 비경구 투여제로 제제화할 수 있다.When applied to pharmaceuticals can be formulated as an oral or parenteral dosage form in the form of a solid, semi-solid or liquid by adding a commercially available inorganic or organic carrier with the compound Schulsin according to the present invention as an active ingredient.

경구투여을 위한 제재로서는 정제(錠劑), 환제(丸劑), 과립제(顆粒劑), 연·경 캡슐제, 산제, 세립제, 분제, 유탁제(乳濁濟), 시럽제, 펠렛제 등을 들 수 있다. 비경구 투여를 위한 제재로는 주사제, 점적제, 연고, 로션, 스프레이, 현탁제, 유제, 좌제(坐劑) 등을 들 수가 있다. 본 발명의 유효성분을 제제화하기 위하여는 상법에 따라서 실시하면 용이하게 제제화할 수 있으며 계면활성제, 부형제, 착색료, 향신료, 보존료, 안정제, 완충제, 현탁제, 기타 상용하는 보조제를 적당히 사용할 수 있다.Examples of preparations for oral administration include tablets, pills, granules, soft and hard capsules, powders, fine granules, powders, emulsions, syrups and pellets. have. Preparations for parenteral administration include injections, drops, ointments, lotions, sprays, suspensions, emulsions, suppositories, and the like. In order to formulate the active ingredient of the present invention, it can be easily formulated according to the conventional method, and surfactants, excipients, coloring agents, spices, preservatives, stabilizers, buffers, suspensions, and other commonly used auxiliaries can be suitably used.

이하 본 발명의 구체적인 방법을 실시예를 들어 단계별로 설명하고자 하지만 본 발명의 권리범위는 이들 실시예에만 한정되는 것은 아니다.Hereinafter, the specific method of the present invention will be described step by step with reference to Examples, but the scope of the present invention is not limited only to these Examples.

실시예 1 : 벤조퓨란계 화합물 슐러신의 분리 및 정제Example 1 Isolation and Purification of the Benzofuran Compound Schleusin

젖비단 그물버섯 자실체를 메탄올에 3일간 침지하여 실온에서 추출하였다. 상기 메탄올 추출물을 감압농축한 후 남은 잔여물을 에틸아세테이트로 추출하고 상기 추출물을 감압농축하여 CHCl3:MeOH를 전개용매로 하여 실리카겔 컬럼 크로마토그래피를 실시하였다. 위에서 얻은 활성분획을 농축한 후 CHCl3:MeOH(2:1)을 전개용매로 하여 세파덱스 엘에이치-20 컬럼 크로마토그래피(Sephadex LH-20 column chromatography)를 수행하여 신규 벤조 퓨란계 화합물 슐러신 15㎎을 분리하였다.Lactose silk mushroom fruiting bodies were immersed in methanol for 3 days and extracted at room temperature. The methanol extract was concentrated under reduced pressure, and the remaining residue was extracted with ethyl acetate, and the extract was concentrated under reduced pressure, and subjected to silica gel column chromatography using CHCl 3 : MeOH as a developing solvent. After concentrating the active fraction obtained above, Sepadex LH-20 column chromatography was performed using CHCl 3 : MeOH (2: 1) as a developing solvent. Was separated.

실시예 2 : 벤조퓨란계 화합물 슐러신의 물리화학적 특성 및 화학구조 분석Example 2 Analysis of Physicochemical Properties and Chemical Structure of Benzofuran Compound Schulsin

상기와 같이 얻은 화합물 슐러신은 황색의 분말이었으며 EI-mass 측정 결과 분자량이 370임을 알 수 있었다. 고분해능 EI-mass 측정 결과 상기 화합물의 분자식이 C19H14O8임을 결정할 수 있었다. UV 스펙트럼을 측정한 결과 223, 261, 311, 348 nm에서 극대흡수피크를 나타내었으며 IR 스펙트럼을 측정한 결과 3412 cm-1에서 히드록시기(hydroxyl group), 1728 및 1703 cm-1에서 카보닐기(carbonyl group)에 기인하는 밴드들이 관찰되었다. 선광도는 각각 +4°이었다.Compound Schlussin obtained as described above was a yellow powder and the molecular weight was 370 by EI-mass measurement. As a result of high resolution EI-mass measurement, the molecular formula of the compound was determined to be C 19 H 14 O 8 . UV spectra showed maximum absorption peaks at 223, 261, 311, and 348 nm, and IR spectra showed hydroxyl groups at 3412 cm -1 and carbonyl groups at 1728 and 1703 cm -1 . ) Bands were observed. The fluorescence was + 4 ° each.

실시예 3 : 디피피에이치(DPPH) 라디칼 소거 활성 조사Example 3 Investigation of DPPH Radical Scavenging Activity

슐러신 100㎍을 20㎕의 메탄올에 녹인후 150μM의 디피피에이치 에탄올 용액 980㎕에 부가하였다. 볼텍스를 이용하여 상기 용액을 잘 섞은후 실온에서 20분간 방치하고 517 nm에서 흡광도를 측정하였다. 대조구로서 동일농도인 100 ㎍/㎖의 BHA(butylated hydroxyanisole)와 비타민 E를 사용하였다. 그 결과 슐러신 30%, BHA 76%, 비타민 E 73%의 디피피에이치(DPPH) 라디칼 소거 활성을 나타내었다. 비록 슐러신이 대조구보다 낮은 활성을 나타내었으나 본 화합물은 식용버섯으로부터 분리되어 독성이 없으며 또한 새로운 골격의 항산화제를 제공할 수 있는 장점이 있다.100 μg of Schusin was dissolved in 20 μl of methanol and added to 980 μl of 150 μM DPH ethanol solution. The solution was mixed well using a vortex and left at room temperature for 20 minutes, and the absorbance was measured at 517 nm. As a control, the same concentration of 100 ㎍ / ㎖ BHA (butylated hydroxyanisole) and vitamin E was used. As a result, it showed a DPPH radical scavenging activity of 30% of sucrose, 76% of BHA, and 73% of vitamin E. Although Schulsine showed lower activity than the control, the compound is isolated from edible mushrooms and is not toxic and has the advantage of providing a new skeleton antioxidant.

실시예 4 : 젖비단그물버섯 추출물을 함유하는 화장품 제조Example 4 Preparation of Cosmetics Containing Lactobacillus Extract

상기 실시예 1에서 얻은 젖비단그물버섯 추출물을 일정 중량% 첨가하여 일반적인 종래 공정에 따라 화장수, 화장용 크림 및 팩제를 제조하였다. 상기 각 제형의 배합성분 및 각 배합성분의 중량%를 하기 표 1, 2 및 3에 나타내었다.By adding a certain weight% lactose net mushroom extract obtained in Example 1 to prepare a lotion, cosmetic cream and pack according to a conventional conventional process. The blending ingredients of each formulation and the weight percentage of each blending component are shown in Tables 1, 2, and 3 below.

화장수toilet water 배합성분Ingredient 중량%weight% 젖비단그물버섯 추출물Lactobacillus net mushroom extract 1.01.0 글리세린glycerin 5.05.0 폴리옥시에틸렌소비탄모노라우레이트Polyoxyethylene sorbitan monolaurate 1.51.5 에탄올ethanol 10.010.0 방부제, 산화방지제Preservatives, Antioxidants 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water to 100to 100

영양크림Nutrition Cream 배합성분Ingredient 중량%weight% 젖비단그물버섯 추출물Lactobacillus net mushroom extract 0.30.3 글리세린glycerin 5.05.0 스테아릴알콜Stearyl alcohol 5.05.0 스테아릭산Stearic acid 8.08.0 스쿠란Skuran 10.010.0 자기유화형글리세릴모노스테아레이트Self-emulsifying glyceryl monostearate 3.03.0 폴리옥시에틸렌세틸에테르Polyoxyethylene cetyl ether 1.01.0 프로필렌글리콜Propylene glycol 5.05.0 수산화칼륨Potassium hydroxide 0.30.3 방부제, 산화방지제Preservatives, Antioxidants 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water to 100to 100

팩제Pack 배합성분Ingredient 중량%weight% 젖비단그물버섯 추출물Lactobacillus net mushroom extract 1.01.0 초산비닐수지에멀젼Vinyl acetate resin emulsion 15.015.0 폴리비닐알코올Polyvinyl alcohol 10.010.0 올리브유olive oil 3.03.0 글리세린glycerin 5.05.0 산화티탄Titanium oxide 8.08.0 가오린Gaolin 7.07.0 에탄올ethanol 5.05.0 방부제, 산화방지제Preservatives, Antioxidants 미량a very small amount 향료Spices 미량a very small amount 정제수Purified water to 100to 100

이상, 상기 실시예를 통하여 설명한 바와 같이 본 발명의 화합물 슐러신은 항산화활성을 가질뿐만 아니라 식용버섯인 젖비단그물버섯으로부터 추출분리하여 세포 독성이 없어 의약품, 화장품 및 식품산업상 매우 유용한 발명인 것이다.As described above, the compound Schulsine of the present invention, as described through the above examples, has an antioxidant activity and extracts and isolates from edible mushrooms, which are edible mushrooms.

Claims (2)

하기 화학식 I로 표시되는 것을 특징으로 하는 신규한 벤조퓨란계 화합물.A novel benzofuran compound represented by the following formula (I). [화학식 I][Formula I] 제 1항의 화합물을 유효성분으로 함유하는 항산화성 조성물.An antioxidant composition containing the compound of claim 1 as an active ingredient.
KR1020010070086A 2001-11-12 2001-11-12 Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material Ceased KR20030039143A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010070086A KR20030039143A (en) 2001-11-12 2001-11-12 Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010070086A KR20030039143A (en) 2001-11-12 2001-11-12 Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material

Publications (1)

Publication Number Publication Date
KR20030039143A true KR20030039143A (en) 2003-05-17

Family

ID=29568946

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010070086A Ceased KR20030039143A (en) 2001-11-12 2001-11-12 Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material

Country Status (1)

Country Link
KR (1) KR20030039143A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07215852A (en) * 1994-01-31 1995-08-15 Kobe Steel Ltd Immunosuppressant

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07215852A (en) * 1994-01-31 1995-08-15 Kobe Steel Ltd Immunosuppressant

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
J Nat Prod. 2001 Sep;64(9):1230-1 *
한국미생물생명공학회지. Vol. 29, No. 3, 149-154, 2001 *

Similar Documents

Publication Publication Date Title
Nessa et al. Free radical-scavenging activity of organic extracts and of pure flavonoids of Blumea balsamifera DC leaves
Jung et al. Antioxidant flavonoids and chlorogenic acid from the leaves of Eriobotrya japonica
Gontijo et al. Leishmanicidal, antiproteolytic and antioxidant evaluation of natural biflavonoids isolated from Garcinia brasiliensis and their semisynthetic derivatives
US20240270779A1 (en) Novel phenylpropanoid compound
EP4321518A1 (en) Novel polyphenol compound
KR100833121B1 (en) Novel compounds with active oxygen scavenging activity, preparation method thereof and composition comprising the same
JP6923100B1 (en) New isoflavone compound
KR100466031B1 (en) Novel antioxidative compounds from Daldinia concentrica and antioxidative composition comprising it as an active material
KR20030039143A (en) Novel benzofuran compound from Suillus granulatus and antioxidative composition comprising it as an active material
KR100330137B1 (en) Novel triterpene-series chemical compound capable of inhibiting lipid-peroxidation and process for preparation thereof
KR101309114B1 (en) Isoindolinone affiliated antioxidation compound isolated from Daldinia concentrica and isolation method thereof
KR20010008772A (en) Hispidin-series chemical compound capable of removing active oxygen and process for prepration thereof
JP5567499B2 (en) Novel substances isolated from orchidaceae plants, extracts containing them, antioxidants, antibacterial agents, anticancer agents and anti-inflammatory agents
KR101054943B1 (en) Phenolic Compounds with Antioxidant Activity from Coding Tea Extract and Functional Foods Comprising the Same as Active Ingredients
KR20180013666A (en) Antioxidant composition comprising uldavioside A
KR20020013237A (en) Chamchi (Aster scaber) extracts and compounds with hypocholesterolemic, antioxidative and antiviral activities
KR102711584B1 (en) Novel anti-inflammatory compound and pharmaceutical composition for preventing or treating inflammatory diseases comprising the same as an active ingredient
US20250134799A1 (en) Composition containing nero di troia pomace extract
KR100811614B1 (en) Antioxidant Activity Extract from Pleurotus eryngii Mycelia Culture, Compound with Novel Oxygen Oxygen Ability Isolated from It, and Manufacturing Method Thereof
KR100882194B1 (en) Compound isolated from sesame extract with antihyperlipidemic, antioxidant and antiviral activity
KR20010057776A (en) Skin whitening agent
KR100371085B1 (en) New ellagitannin glycosides
Ansari et al. Isolation, Structure Elucidation, and Antioxidant Activity of Chemical Constituents from Artocarpus lakoocha Fruits
JP4182230B2 (en) Novel glycoside, process for producing the same and composition
KR20250007830A (en) Antioxidant compounds derived from Sargassum macrocarpum and use thereof

Legal Events

Date Code Title Description
A201 Request for examination
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 20011112

PA0201 Request for examination
PG1501 Laying open of application
E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20040130

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20040430

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20040130

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I